TYP 0.00% 2.1¢ tryptamine therapeutics limited

Ann: Exopharm Gains US Patent for LEAP Technology, page-8

  1. 16,819 Posts.
    lightbulb Created with Sketch. 356
    I'd say a deal is or has been around the corner for some time. Sometimes it doesn't happen . Sometimes it takes time . Sometimes a long time.

    If he says nothing people say why doesn't he tell us what's happening . Therefore nothing must be happening.

    Fwwiw Dixon is a stickler for the rules and formalities and has a high moral ethic . He's simply putting forward the situation as he believes it to be. It doesn't mean it hasn't worked out or won't .Or that unforeseen issues haven't arisen.

    It's a big step getting a US patent . They're in with the Finnish Blood bank . Showa Denko want to do business with them. The large US and European bios have naturally become more insular and focused on the massive issues in their own backyard during covid. That's made it tough. But Dixon will do what he said . Even if it takes a lot longer than anyone hoped.

    But you should sit it out if that's your gut feel. Never go against that.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.000(0.00%)
Mkt cap ! $22.87M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
4 1037060 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 150000 1
View Market Depth
Last trade - 10.09am 05/08/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.